U.S. employers covering weight-loss drugs could nearly double in 2024 - survey

Explore stories from Atlantic Canada.

A Local Culinary Adventure: inspired by Halifax's Seaport Market | SaltWire #cooking #cookingtips - The number of U.S. employers who cover obesity medications, including Wegovy from Novo Nordisk that belongs to a class of GLP-1 drugs, could nearly double next year, according to a survey.

"For the 43% planning to offer coverage next year, we recommend a physician-led approach that guides who should be prescribed GLP-1 medications and how to make them part of a holistic health management plan," Accolade Associate Chief Medical Officer James Wantuck said. Employers that cover weight-loss drugs are facing a spike in their healthcare costs because of the growing popularity of Wegovy.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SaltWire Network /  🏆 45. in CA

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Factbox-What is Lebanon's Hezbollah?Explore stories from Atlantic Canada.
Read more »

Factbox-What is Lebanon's Hezbollah?Explore stories from Atlantic Canada.
Read more »

Cricket-Australia bat first against spin-heavy India in World Cup openerExplore stories from Atlantic Canada.
Read more »

RICK MacLEAN: You WILL pay for your news. No, really.Explore stories from Atlantic Canada.
Read more »

Saturday selectionsExplore stories from Atlantic Canada.
Read more »

RICK MacLEAN: You WILL pay for your news. No, really.Explore stories from Atlantic Canada.
Read more »